Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quotient Clinical Expands Pharma Capacity | Contract Pharma
Breaking News

Quotient Clinical Expands Pharma Capacity

Doubles capacity with a second GMP manufacturing facility and new formulation development and analysis labs

Quotient Clinical is expanding its pharmaceutical sciences capabilities, doubling capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis labs.
 
The new labs, based within the company’s Nottingham facility, will provide formulation development services with a footprint of approximately 8,000 sq.-ft. The new GMP manufacturing facility, located in the MediCity innovation hub in Nottingham, has a footprint of 3,000 sq.-ft. and comprises eight multipurpose suites for the manufacture of drug products on a large scale, with the necessary containment controls to handle high potency molecules. The facility is scheduled to become operational later in 2015 following an MHRA inspection.
 
Mark Egerton, chief executive officer Quotient Clinical said, “This expansion is in direct response to the increasing demand for our Translational Pharmaceutics services. Our approach of integrating formulation development, real-time GMP manufacturing and clinical testing is proving an attractive option to reduce development timelines and associated costs.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters